EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses

Antti Mustonen, Solja Niemelä, Alexander Denissoff, Antti Tanskanen, Ellenor Mittendorfer-Rutz, Markku Lähteenvuo iD, Jari Tiihonen, Heidi Taipale

Acta Psychiatrica Scandinavica · 2026-08 · 154 (2) · 142-152

DOI: 10.1111/acps.70097 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Acta Psychiatrica Scandinavica, online erschienen am 08.04.2026. Verfasst von Antti Mustonen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Hauptthemen laut MEDLINE: Marijuana Abuse, Psychoses, Substance-Induced, Psychotic Disorders, Substance-Related Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Juho Vainion Säätiö, Alkoholitutkimussäätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Research indicates that first‐episode psychosis (FEP) with cannabis use disorder (CUD) carries a substantial disease burden, but more granular clinical trajectories of cannabis‐related psychoses remain unclear. This study examines the clinical trajectories of first clinically diagnosed FEP&CUD and cannabis‐induced psychosis (CIP) in comparison with FEP without substance use disorder (SUD).

Methods

From the linkage of nationwide administrative and medical registers of Sweden (2006–2021), we identified 1772 individuals (84.1% men) with incident CIP, 1360 individuals (84.3% men) with FEP&CUD and matched individuals with FEP but without SUD and followed them up until 2023. We compared annual prevalence of psychiatric diagnoses before and after cohort entry, medication use, days in inpatient care, and the risks of hospitalization for psychosis and death.

Results

Mean age at first diagnosis was 26.6 years (SD 8.3) for incident CIP and 26.9 years (SD 8.4) for FEP&CUD and FEP without SUD. Individuals in the FEP without SUD cohort were more likely to have a record of schizophrenia diagnosis compared to the FEP&CUD and CIP cohorts during the first (14.41%, 6.25%, 2.37%) and second year (10.88%, 7.13%, 3.27%) after cohort entry. However, FEP&CUD and CIP cohorts had a more pronounced burden of inpatient treatment as well as elevated risks of hospitalization for psychosis (aHR = 1.66; 95% CI 1.49–1.86 and aHR = 1.47; 1.32–1.64) and death (aHR = 2.02; 1.44–2.82 and aHR = 1.80; 1.30–2.50) compared to individuals with FEP without SUD.

Conclusions

Cannabis‐related psychoses, that is, FEP&CUD and CIP, were associated with poor outcomes, including high risk of hospitalization for psychosis and increased mortality, underscoring the need for targeted interventions. Moreover, the overlapping clinical trajectories suggest that cannabis‐related psychoses may not represent clinically distinct entities but instead lie on a continuum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Marijuana AbusePsychoses, Substance-InducedPsychotic DisordersSubstance-Related DisordersHumansSwedenAdultMaleFemaleHospitalizationRegistriesYoung AdultSchizophreniaPrevalence

Stichwörter der Autor:innen

cannabis‐induced psychosisfirst‐episode psychosishospitalizationmortalityoutcomeregister studytrajectory

Autor:innen und Institutionen

  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Department of Psychiatry, Seinäjoki Central Hospital, Seinäjoki, Finland.
  • Department of Psychiatry, Faculty of Medicine, University of Turku, Turku, Finland.
  • Mental Health and Addiction Services, Wellbeing County of South-West Finland, Turku, Finland.
  • Department of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, Kuopio, Finland.

ORCID-Profile: Markku Lähteenvuo

Förderung

  • Vetenskapsrådet
  • Juho Vainion Säätiö
  • Alkoholitutkimussäätiö
  • State funding for university- level health research, Tampere University Hospital

Zitieren

APA

Mustonen, A., Niemelä, S., Denissoff, A., Tanskanen, A., Mittendorfer-Rutz, E., Lähteenvuo, M., Tiihonen, J., & Taipale, H. (2026). Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses. Acta Psychiatrica Scandinavica, 154(2), 142-152. https://doi.org/10.1111/acps.70097

Vancouver

Mustonen A, Niemelä S, Denissoff A, Tanskanen A, Mittendorfer-Rutz E, Lähteenvuo M, et al. Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses. Acta Psychiatrica Scandinavica. 2026;154(2):142-152. doi:10.1111/acps.70097

BibTeX
@article{Mustonen2026,
  author = {Mustonen, Antti and Niemelä, Solja and Denissoff, Alexander and Tanskanen, Antti and Mittendorfer-Rutz, Ellenor and Lähteenvuo, Markku and Tiihonen, Jari and Taipale, Heidi},
  title = {Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses},
  journal = {Acta Psychiatrica Scandinavica},
  year = {2026},
  volume = {154},
  number = {2},
  pages = {142--152},
  doi = {10.1111/acps.70097}
}
Kostenlos starten →